Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Ending Cash Balance (2024 - 2026)

Updated

Analysis

Revium Rx (RVRC) Ending Cash Balance (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,149.24 Bn 1,117.83 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.01 Bn 555.87 Bn 17.30 Bn 16.91 Bn
3 AbbVie 500.63 Bn 473.74 Bn 12.70 Bn 6.57 Bn
4 Merck 357.88 Bn 312.26 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 301.63 Bn 265.62 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn 4.88 Bn
7 Amgen 238.20 Bn 193.60 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.85 Bn 169.05 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.94 Bn 118.58 Bn 10.94 Bn 1.03 Bn
10 Revium Rx 86.84 Mn 86.00 Mn - 842,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 842,000.00
Dec 31, 2025 1.68 Mn
Jun 30, 2025 3.65 Mn
Dec 31, 2024 3.27 Mn
API Access

Revium Rx Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=RVRC&period=max&api_key=YOUR_API_KEY